Canada seeks regulatory change to lower drug prices

Canada has launched proposals to amend regulations covering patented medicines, saying it hopes to “better protect Canadian consumers from the high prices of patented drugs.”

The proposals include revising the list of countries against which Canada’s patented drug prices would be compared, as well as introducing new regulatory factors for the country’s medicines regulator to take into consideration when evaluating pricing.

The changes would have the effect of lowering prices for public drug plans.